Evidence map›Paper›PMID 36132895›Full record

ArticleNanoscale advances2020

Continuously manufactured single-core iron oxide nanoparticles for cancer theranostics as valuable contribution in translational research.

Regina Bleul, Abdulkader Baki, Christian Freese, Hendrik Paysen, Olaf Kosch, Frank Wiekhorst

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Whither Magnetic Hyperthermia? A Tentative Roadmap.Materials (Basel, Switzerland) · 2021
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Regina BleulFraunhofer Institute for Microengineering and Microsystems (IMM) Carl-Zeiss-Strasse 18-20 55129 Mainz Germany regina.bleul@imm.fraunhofer.de.ORCID https://orcid.org/0000-0003-0352-7193
Abdulkader BakiFraunhofer Institute for Microengineering and Microsystems (IMM) Carl-Zeiss-Strasse 18-20 55129 Mainz Germany regina.bleul@imm.fraunhofer.de.
Christian FreeseFraunhofer Institute for Microengineering and Microsystems (IMM) Carl-Zeiss-Strasse 18-20 55129 Mainz Germany regina.bleul@imm.fraunhofer.de.ORCID https://orcid.org/0000-0001-8411-1573
Hendrik PaysenPhysikalisch-Technische Bundesanstalt Abbestr. 2-12 10587 Berlin Germany.ORCID https://orcid.org/0000-0002-0056-141X
Olaf KoschPhysikalisch-Technische Bundesanstalt Abbestr. 2-12 10587 Berlin Germany.ORCID https://orcid.org/0000-0002-6740-8217
Frank WiekhorstPhysikalisch-Technische Bundesanstalt Abbestr. 2-12 10587 Berlin Germany.ORCID https://orcid.org/0000-0003-0608-1473
Carl Zeiss (Germany) · DEPhysikalisch-Technische Bundesanstalt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Micromixer technology was used to manufacture magnetic single core iron oxide nanoparticles that combine imaging as well as therapeutic functions. In a continuous, scalable and highly controllable manner, synthesis with biocompatible educts

Identifiers

PMID36132895
PMCPMC9417974
OpenAlexW3076416175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.